PLoS ONE (Jan 2021)

Bioinformatics prediction of differential miRNAs in non-small cell lung cancer.

  • Kui Xiao,
  • Shenggang Liu,
  • Yijia Xiao,
  • Yang Wang,
  • Zhiruo Zhu,
  • Yaohui Wang,
  • De Tong,
  • Jiehan Jiang

DOI
https://doi.org/10.1371/journal.pone.0254854
Journal volume & issue
Vol. 16, no. 7
p. e0254854

Abstract

Read online

BackgroundNon-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers. The drug resistance of NSCLC has clinically increased. This study aimed to screen miRNAs associated with NSCLC using bioinformatics analysis. We hope that the screened miRNA can provide a research direction for the subsequent treatment of NSCLC.MethodsWe screened out the common miRNAs after compared the NSCLC-related genes in the TCGA database and GEO database. Selected miRNA was performed ROC analysis, survival analysis, and enrichment analysis (GO term and KEGG pathway).ResultsA total of 21 miRNAs were screened in the two databases. And they were all highly expressed in normal and low in cancerous tissues. Hsa-mir-30a was selected by ROC analysis and survival analysis. Enrichment analysis showed that the function of hsa-mir-30a is mainly related to cell cycle regulation and drug metabolism.ConclusionOur study found that hsa-mir-30a was differentially expressed in NSCLC, and it mainly affected NSCLC by regulating the cell cycle and drug metabolism.